Kestra Medical Technologies, Ltd. (KMTS) vs Pulse Biosciences, Inc (PLSE)

Kestra Medical Technologies, Ltd. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.3B against $1.7B — 1.9× the size. Kestra Medical Technologies, Ltd. grew revenue faster over the last twelve months: 60.7% against −23.3%. Kestra Medical Technologies, Ltd. has the higher net margin (−140.4% vs −6,755.8%) and the lower return on invested capital (−93.5% vs 0.00%). Across the 17 metrics below, Kestra Medical Technologies, Ltd. leads on 11 and Pulse Biosciences, Inc on 6.

Valuation

Metric KMTS PLSE Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 14.95 2,585.22 2.52
P/B 7.17 30.79 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 13.76 2,554.99 2.88
Earnings yield (9.80%) (2.67%) (2.67%)
Free cash flow yield (7.71%) (2.00%) 0.09%

Profitability

Metric KMTS PLSE Medical Instruments & Supplies median
Gross margin 53.89% 0.25% 54.29%
Operating margin (134.48%) (7,007.76%) 1.07%
Net margin (140.43%) (6,755.78%) (1.61%)
Free cash flow margin (115.31%) (5,180.42%) 1.08%
Return on equity (73.74%) (78.49%) (1.32%)
Return on assets (48.85%) (67.90%) 0.00%
Return on invested capital (93.49%) 0.00% 0.00%

Growth

Metric KMTS PLSE Medical Instruments & Supplies median
Revenue growth (TTM) 60.72% (23.25%) 8.85%
EPS growth (last fiscal year) 52.63% (17.39%) 8.65%
Revenue growth, 5-year CAGR — — 9.17%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KMTS PLSE Medical Instruments & Supplies median
Debt to equity 0.33 0.00 0.10
Current ratio 4.69 9.63 2.48
Net debt to EBITDA 1.24 1.06 0.89

Dividend

Metric KMTS PLSE Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric KMTS PLSE Medical Instruments & Supplies median
Market cap 1.71b 3.31b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack